Intranasal nicotine for postoperative pain treatment

Anesthesiology

Volumn 101, Issue 6, 2004, Pages 1417-1421

  Flood, Pamela ^a   Daniel, Danette ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NICOTINE; PLACEBO;

ADULT; AEROSOL; ANALGESIA; ANESTHESIST; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG EFFICACY; DRUG UTILIZATION; FEMALE; GENERAL ANESTHESIA; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INCISION; MEASUREMENT; NORMAL HUMAN; PAIN ASSESSMENT; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SURGICAL PATIENT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TIME; UTERUS SURGERY;

EID: 9444245277     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200412000-00023     Document Type: Article

References (35)

1. Svensson I, Sjostrom B, Haljamae H: Assessment of pain experiences after elective surgery. J Pain Symptom Manage 2000; 20:193-201
2. Owen H, McMillan V, Rogowski D: Postoperative pain therapy: A survey of patients' expectations and their experiences. Pain 1990; 41:303-7
3. Thomas T, Robinson C, Champion D, McKell M, Pell M: Prediction and assessment of the severity of postoperative pain and of satisfaction with management. Pain 1998; 75:177-85
4. Decker MW, Meyer MD, Sullivan JP: The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control. Expert Opin Investig Drugs 2001; 10:1819-30
5. Flores CM: The promise and pitfalls of a nicotinic cholinergic approach to pain management. Pain 2000; 88:1-6
6. Perkins K, Grobe J, Stiller R, Scierka A, Goettler J, Reynolds W, Jennings J: Effects of nicotine on thermal pain detection in humans. Exp Clin Psychopharmacol 1994; 2:95-106
7. Fertig JB, Pomerleau OF, Sanders B: Nicotine-produced antinociception in minimally deprived smokers and ex-smokers. Addict Behav 1986; 11:239-48
8. Pomerleau OF: Nicotine as a psychoactive drug: Anxiety and pain reduction. Psychopharmacol Bull 1986; 22:865-9
9. Jamner LD, Girdler SS, Shapiro D, Jarvik ME: Pain inhibition, nicotine, and gender. Exp Clin Psychopharmacol 1998; 6:96-106
10. Damaj MI: Influence of gender and sex hormones on nicotine acute pharmacological effects in mice. J Pharmacol Exp Ther 2001; 296:132-40
11. Flood P, Daniel D: Pronociceptive actions of isoflurane: A protective role for estrogen. ANESTHESIOLOGY 2003; 99:1-4
12. Lavand'homme PM, Eisenach JC: Sex differences in cholinergic analgesia II: Differing mechanisms in two models of allodynia. ANESTHESIOLOGY 1999; 91:1455-61
13. Goodman SR, Kim-Lo SH, Ciliberto CF, Ridley DM, Smiley RM: Epinephrine is not a useful addition to intrathecal fentanyl or fentanyl-bupivacaine for labor analgesia. Reg Anesth Pain Med 2002; 27:374-9
14. Fislibein L, O'Brien P, Hutson A, Theriaque D, Stacpoole PW, Flotte T: Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function. J Investig Med 2000; 48:435-40
15. Perkins KA, Gerlach D, Broge M, Sanders M, Grobe J, Fonte C, Cherry C, Wilson A, Jacob R: Quitting cigarette smoking produces minimal loss of chronic tolerance to nicotine. Psychopharmacology (Berl) 2001; 158:7-17
16. Schneider NG, Lunell E, Olmstead RE, Fagerstrom KO: Clinical pharmacokinetics of nasal nicotine delivery: A review and comparison to other nicotine systems. Clin Pharmacokinet 1996; 31:65-80
17. Sipe RV 3rd, Buck DC, Hollinger JO: Nicotine administration in rabbits using Habitrol nicotine patches and nicotine nasal spray. Clin Exp Pharmacol Physiol 2000; 27:480-2
18. Perkins KA, Grobe JE, Fonte C, Goettler J, Caggiula AR, Reynolds WA, Stiller RL, Scierka A, Jacob RG: Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 1994; 270:628-38
19. Sutherland G, Russell MA, Stapleton J, Feyerabend C, Ferno O: Nasal nicotine spray: A rapid nicotine delivery system. Psychopharmacology (Berl) 1992; 108:512-8
20. Guthrie SK, Zubieta JK, Ohl L, Ni L, Koeppe RA, Minoshima S, Domino EF: Arterial/venous plasma nicotine concentrations following nicotine nasal spray. Eur J Clin Pharmacol 1999; 55:639-43
21. Benowitz NL, Zevin S, Jacob P 3rd: Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol 1997; 43:259-67
22. Schoffelmeer AN, De Vries TJ, Wardeh G, van de Ven HW, Vanderschuren LJ: Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci 2002; 22:3269-76
23. Wang H, Yu M, Ochani M, Amelia CA, Tanovic M, Susarla S, Li JH, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384-8
24. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, Sudan S, Czura CJ, Ivanova SM, Tracey KJ: Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002; 195:781-8
25. Hjalmarson A, Franzon M, Westin A, Wiklund O: Effect of nicotine nasal spray on smoking cessation: A randomized, placebo-controlled, double-blind study. Arch Intern Med 1994; 154:2567-72
26. Kunze U, Schoberberger R, Schmeiser-Rieder A, Groman E, Kunze M: Alternative nicotine delivery systems (ANDS): Public health aspects. Wien Klin Wochenschr 1998; 110:811-6
27. Jorenby DE: New developments in approaches to smoking cessation. Curr Opin Pulm Med 1998; 4:103-6
28. Schneider NG, Olmstead R, Mody FV, Doan K, Franzon M, Jarvik ME, Steinberg C: Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial. Addiction 1995; 90:1671-82
29. Sutherland G, Stapleton JA, Russell MA, Jarvis MJ, Hajek P, Belcher M, Feyerabend C: Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992; 340:324-9
30. Flood P, Ramirez-Latorre J, Role L: Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected. ANESTHESIOLOGY 1997; 86:859-65
31. Greenland S, Satterfield MH, Lanes SF: A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf 1998; 18:297-308
32. Kenny GN: Risk factors for postoperative nausea and vomiting. Anaesthesia 1994; 49 Suppl:6-10
33. Carstens E, Anderson KA, Simons CT, Carstens MI, Jinks SL: Analgesia induced by chronic nicotine infusion in rats: Differences by gender and pain test. Psychopharmacology (Berl) 2001; 157:40-5
34. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Lena C, Le Novere N, de Kerchove d'Exaerde A, Huchet M, Damaj MI, Changeux JP: Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 1999; 398:805-10
35. Damaj MI, Meyer EM, Martin BR: The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology 2000; 39:2785-91